-+ 0.00%
-+ 0.00%
-+ 0.00%
Excalibur Co., Ltd. announced that the board of directors of the company reviewed and passed a bill to shut down, adjust and transform the subsidiary's production line: shut down the Ma'anshan New Pentylene Glycol Production Line, a wholly-owned subsidiary, and rebuild a polyester resin project with an annual output of 100,000 tons. The project is expected to have a total investment of 180 million yuan. The investment period is 24 months, and the capital is raised by the company itself; shut down the participating subsidiary Lihuayi Excalibur's neopentylene glycol production line and seek potential partners and buyers for the business and assets of the two companies mentioned above. This adjustment is not expected to have a significant impact on the company's 2026 results.
Share
Listen to the news
Excalibur Co., Ltd. announced that the board of directors of the company reviewed and passed a bill to shut down, adjust and transform the subsidiary's production line: shut down the Ma'anshan New Pentylene Glycol Production Line, a wholly-owned subsidiary, and rebuild a polyester resin project with an annual output of 100,000 tons. The project is expected to have a total investment of 180 million yuan. The investment period is 24 months, and the capital is raised by the company itself; shut down the participating subsidiary Lihuayi Excalibur's neopentylene glycol production line and seek potential partners and buyers for the business and assets of the two companies mentioned above. This adjustment is not expected to have a significant impact on the company's 2026 results.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending